INVO Bioscience (NASDAQ:INVO) Shares Down 4.5% – Here’s What Happened

by · The Cerbat Gem

INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) dropped 4.5% during mid-day trading on Monday . The stock traded as low as $0.81 and last traded at $0.81. Approximately 19,996 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 1,587,563 shares. The stock had previously closed at $0.85.

INVO Bioscience Price Performance

The firm has a 50 day moving average price of $0.79 and a 200-day moving average price of $0.83.

Institutional Trading of INVO Bioscience

A hedge fund recently bought a new stake in INVO Bioscience stock. CWC Advisors LLC. bought a new stake in INVO Bioscience, Inc. (NASDAQ:INVO – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned about 2.64% of INVO Bioscience at the end of the most recent reporting period. Institutional investors own 12.02% of the company’s stock.

INVO Bioscience Company Profile

(Get Free Report)

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

Read More